![](https://www.ingenza.com/wp-content/themes/ingenza2022/images/hosts/cho-cells.jpg)
Host
- CHO cell-line
- Serum-free and adapted to suspension growth
![](https://www.ingenza.com/wp-content/themes/ingenza2022/images_2022/case-studies/case-study-6/diagram1.jpg)
Selection & USP
- Codon optimisation, chaperone-enhanced, clonal selection
- 3L scalable batch/perfusion process established
![](https://www.ingenza.com/wp-content/themes/ingenza2022/images_2022/case-studies/case-study-6/diagram2.jpg)
DSP
- 3-step chromatographic DSP
- Viral inactivation & removal (nanofiltration >85% recovery)
![](https://www.ingenza.com/wp-content/themes/ingenza2022/images_2022/case-studies/case-study-6/image1.jpg)
Pre-clinical material
- Fill and finish (outsourced)
- Freeze-drying (outsourced)
- Release assays
- Drug product completed pre-clinical toxicology